BSE Live
Jan 30, 16:00Prev. Close
0.83
Open Price
0.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of SUPHA PHARMACHEM (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.73 | 0.04 | -0.01 | 0.02 | -0.35 | |
| Net CashFlow From Operating Activities | 0.09 | -0.13 | -0.57 | 0.38 | 0.41 | |
| Net Cash Used In Investing Activities | 0.10 | 0.07 | 0.31 | 0.14 | 0.03 | |
| Net Cash Used From Financing Activities | -0.24 | 0.10 | 0.16 | 0.00 | -0.45 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.05 | 0.04 | -0.11 | 0.52 | -0.01 | |
| Cash And Cash Equivalents Begin of Year | 0.19 | 0.14 | 0.56 | 0.04 | 0.06 | |
| Cash And Cash Equivalents End Of Year | 0.14 | 0.19 | 0.46 | 0.56 | 0.04 |
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016